RE: EPO informationYou know what I find hillarious.... Its almost embarrassing to throw out a near term price target like $10 in this forum... but I think you're absolutely right and I think that's a very probable scenario.
What's even funnier is the fact that I would probably dismiss this kind prediction as wildly optimistic if I were reading this and didnt understand the underlying fundamentals.
Its just INCREDIBLE that we are where we are given the very near term potential. The more I look at 1402's apparent efficacy and indications and similarity to EPO, the more I realize how great an opportunity this is in terms of risk reward. Its just staggering to me that there's virtually no spec premium built into the stock on 1402 ALONE!? There are dozens of examples of small biotech spec stocks that are based solely on drug candidates with far less potential and early indications than 1402.
There arent a lot of stocks around where you can have a potential 5-10 bagger on news..... AND have relatively limited downside because all the other value drivers are relatively unaffected by the result of this one trial ....
It seems like its literally going to take a DONE DEAL with an AMGEN or J&J to truly have the market understand what we have.